Tapazole and Potassium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tapazole (methimazole) and Potassium (potassium). Common drug interactions include arthralgia among females and ageusia among males.

The phase IV clinical study analyzes what interactions people have when they take Tapazole and Potassium. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Tapazole?

Tapazole has active ingredients of methimazole. It is often used in hyperthyroidism. eHealthMe is studying from 2,477 Tapazole users. Check the latest studies of Tapazole.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.



On Jul, 07, 2026

21 people who take Tapazole and Potassium together, and have interactions are studied.

Tapazole and Potassium drug interactions.

What are the common drug interactions of Tapazole and Potassium, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Headache (pain in head)
  3. Fatigue (feeling of tiredness)
  4. Abdominal pain
  5. Anaemia (lack of blood)
  6. Diarrhoea
  7. Drug ineffective
  8. Fall
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Mobility decreased (ability to move is reduced)

male:

  1. Ageusia (loss of taste functions of the tongue)
  2. Asthenia (weakness)
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Foreign body in eye (foreign particle in eye)
  5. Haemorrhage (bleeding)
  6. Lacrimation increased
  7. Ligament sprain (ligament stretched)
  8. Photophobia (extreme sensitivity to light)
  9. Swelling face
  10. Cardiac disorder

What are the common drug interactions of Tapazole and Potassium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypersensitivity

40-49:

  1. Diarrhoea
  2. Eye swelling
  3. Swelling face

50-59:

  1. Death
  2. Joint swelling
  3. Libido decreased (loss of interest in sex)
  4. Muscular weakness (muscle weakness)
  5. Nausea (feeling of having an urge to vomit)
  6. Peripheral swelling
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Vomiting

60+:

  1. Ageusia (loss of taste functions of the tongue)
  2. Anaemia (lack of blood)
  3. Cardiac failure congestive
  4. Decreased appetite
  5. Device occlusion
  6. Dysgeusia (disorder of the sense of taste)
  7. Eye pain
  8. Fluid retention (an abnormal accumulation of fluid in the blood)
  9. Foreign body in eye (foreign particle in eye)
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

What are the existing conditions these people have? *

  1. Thyroid Diseases: 3 people, 14.29%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 14.29%
  3. High Blood Pressure: 2 people, 9.52%
  4. Basedow's Disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones): 2 people, 9.52%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 9.52%
  6. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 9.52%
  7. Depression: 2 people, 9.52%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.52%
  9. High Blood Cholesterol: 2 people, 9.52%
  10. Immunodeficiency: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Tapazole and Potassium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tapazole and Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tapazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tapazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methimazole and potassium (the active ingredients of Tapazole and Potassium, respectively), and Tapazole and Potassium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: